Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/25 17:32 | 5/7/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 1 | S.dm | -219 | 27.04 | 0 | -8 | 206 | D | |||||||||||||||
5/9/25 17:01 | 5/7/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 1 | S.d | -5 | 27.00 | 0 | 0 | 0 | 57 | D | ||||||||||||||
5/9/25 16:59 | 5/7/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 2 | S.d | -674 | 25.25 | 0 | -27 | 33 | D | |||||||||||||||
5/5/25 16:54 | 5/2/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Moat Ross | X0 | O | CHIEF CO | 3 | S.dm | -2,919 | 25.24 | 0 | -116 | 9 | D | |||||||||||||||
5/1/25 18:24 | 4/29/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 4 | S.dm | -3,995 | 24.81 | 0 | -161 | 27 | D | |||||||||||||||
4/16/25 16:38 | 4/14/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 2 | S.d | -507 | 20.78 | 0 | -24 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |